émulsion pour perfusion

DRUG2 trials

Sponsors

Hospices Civils De Lyon, Centre Hospitalier Universitaire Grenoble Alpes

Conditions

Respiratory Distress Syndrome of preterm babies born < 32 weeks of gestational agechronic hemodialysis patients (for more than 3 months) with no residual diuresis (<100 mL/day).

Phase 2

CLEARTOX: Development of an innovative haemodialysis method to improve dialytic clearance of protein-bound uraemic toxins

RecruitingCTIS2023-510406-41-00

Hospices Civils De Lyonchronic hemodialysis patients (for more than 3 months) with no residual diuresis (<100 mL/day).

Start: 2025-09-22Target: 12Updated: 2025-06-04

Phase 3

Respiratory effect of the LISA (Less Invasive surfactant administration) method with sedation by propofol versus absence of sedation: Double-blind comparative randomized clinical trial

Active, not recruitingCTIS2024-518836-36-00

Centre Hospitalier Universitaire Grenoble AlpesRespiratory Distress Syndrome of preterm babies born < 32 weeks of gestational age

Start: 2019-10-07Target: 542Updated: 2025-05-16